Psyence Biomedical Ltd. Common Shares
Symbol: PBM (NASDAQ)
4.85
▼ (-8.57%) -0.454
Company Description:
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
Key Stats
- Today's Open: $5.24
- Today's High: $5.479
- Today's Low: $4.573
- Today's Volume: 545.18K
- Yesterday Close: $5.3
- Yesterday High: $5.54
- Yesterday Low: $4.36
- Yesterday Volume: 25.85M
- Last Min Volume: 5
- Last Min High: $4.866
- Last Min Low: $4.848
- Last Min VWAP: $4.866
Company Profile
- Name: Psyence Biomedical Ltd. Common Shares
- Website: https://www.psyence.com
- Listed Date: 2024-01-26
- Location: ,
- Market Status: Active
- CIK Number: 0001985062
- SIC Code:
- SIC description:
- Market Cap: $1.24M
- Round Lot: 100
- Outstanding Shares: 234.28K
- Asset Type: CS
RECENT FILINGS FOR PBM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-05 | 6-K | View |
| 2025-08-28 | 6-K | View |
| 2025-08-06 | F-3 | View |
| 2025-07-25 | 20-F/A | View |
| 2025-07-23 | S-8 | View |
| 2025-06-25 | 20-F | View |
| 2025-06-25 | 6-K | View |
| 2025-06-11 | 6-K | View |
| 2025-05-20 | 6-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-12 | SCHEDULE 13D/A | View |
| 2025-05-06 | 6-K | View |
| 2025-04-23 | 6-K | View |
| 2025-04-11 | 6-K | View |
| 2025-04-01 | 6-K | View |
| 2025-03-31 | 6-K | View |
| 2025-03-25 | SCHEDULE 13D/A | View |
| 2025-03-14 | EFFECT | View |
| 2025-03-13 | CORRESP | View |
Latest News on PBM